IQVIA doesn’t yet have the golden egg of AI, but it’s in ‘incubation’
Gary Shorter, head of AI and data science at healthcare data goliath IQVIA, is not in a rush as he incorporates machine learning into the company’s suite of services. But...
Author: admin
Novartis breast cancer drug approved for ultra-rare condition
Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, granting an accelerated clearance to...
Clarify Health Closes $150M Series D Funding to Unlock the Promise of Value-Based Care with End-to-End Intelligence on Every Patient Journey
April 05, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, announced today that it secured $150 million in Series...
Real-world Data Show Benefits of Increased Lung Cancer Screening but Persistent Disparities
New research published in The BMJ indicates the introduction of low dose CT (LDCT) screening in 2013 coincided with improved survival and a shift toward diagnoses of stage I non–small cell lung...
Cytel appoints first CMO to accelerate the expansion of analytics and innovation
Cytel has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development. Dr...
Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology
Sickle Cell Patients Treated With Endari® had Statistically Significantly Fewer Vaso-Occlusive Events and Hospitalizations Through 72 Weeks Follow-up, Versus Baseline Adverse Events Among These Patients from French Guiana and Qatar were Few and Mild TORRANCE,...
UK pharmaceutical industry seeks to establish health data principles amid plans to unlock NHS data
The UK’s Association of the British Pharmaceutical Industry (ABPI) has recently concluded a consultation on its new draft industry governance principles aimed at guiding the pharmaceutical industry when analysing and using health...
Savana gets $25 million booster to make clinical research more powerful with big data
The Madrid-based company plans to enter the drugs research space while also consolidating its footprint in America and Western Europe Megha Paul 05 April 2022 Real World Data, or the...
Foundation Medicine and Collaborators to Share Scientific Advances at AACR22 Reinforcing the Power of Genomic Testing in Precision Cancer Care
New studies demonstrate the ability of Foundation Medicine’s portfolio of tests to improve treatment options for patients, and reinforce the company’s role as an essential partner to researchers April 05,...
Analysis Group and AstraZeneca Researchers Fill Real-World Data Gap for Providers Treating Severe Asthma Sufferers
BOSTON, April 5, 2022 /PRNewswire/ — Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), and AstraZeneca have published results from their ZEPHYR 1 study, the first real-world...